Conformationally constrained paclitaxel analogs and their use as anticancer and anti-Alzheimers agents
dc.contributor.assignee | Emory University | en |
dc.contributor.assignee | Binghamton University | en |
dc.contributor.assignee | Virginia Tech Intellectual Properties, Inc. | en |
dc.contributor.inventor | Kingston, David G. I. | en |
dc.contributor.inventor | Ganesh, Thota | en |
dc.contributor.inventor | Synder, James Patrick | en |
dc.contributor.inventor | Lakdawala, Ami S. | en |
dc.contributor.inventor | Bane, Susan Lynn | en |
dc.date.accessed | 2016-08-19 | en |
dc.date.accessioned | 2016-08-24T17:54:44Z | en |
dc.date.available | 2016-08-24T17:54:44Z | en |
dc.date.filed | 2005-01-14 | en |
dc.date.issued | 2007-12-25 | en |
dc.description.abstract | Constrained paclitaxel derivatives include a bridge extending from the C-3′ phenyl to either the C4 or -3 positions. Many of the constrained paclitaxel derivatives provide activity comparable or superior to the natural product paclitaxel. | en |
dc.format.mimetype | application/pdf | en |
dc.identifier.applicationnumber | 11035037 | en |
dc.identifier.patentnumber | 7312240 | en |
dc.identifier.uri | http://hdl.handle.net/10919/72577 | en |
dc.identifier.url | http://pimg-fpiw.uspto.gov/fdd/40/122/073/0.pdf | en |
dc.language.iso | en_US | en |
dc.publisher | United States Patent and Trademark Office | en |
dc.subject.cpc | C07D493/10 | en |
dc.subject.uspc | 514/449 | en |
dc.title | Conformationally constrained paclitaxel analogs and their use as anticancer and anti-Alzheimers agents | en |
dc.type | Patent | en |
dc.type.dcmitype | Text | en |
dc.type.patenttype | utility | en |
Files
Original bundle
1 - 1 of 1